Tomita K et al. |
The effect of oxidative stress on histone acetylation and IL-8 release. |
2003 |
Biochem. Biophys. Res. Commun. |
pmid:12565901
|
Maroni P et al. |
Chemical and genetic blockade of HDACs enhances osteogenic differentiation of human adipose tissue-derived stem cells by oppositely affecting osteogenic and adipogenic transcription factors. |
2012 |
Biochem. Biophys. Res. Commun. |
pmid:23085045
|
Takechi S et al. |
Chicken HDAC2 down-regulates IgM light chain gene promoter activity. |
2002 |
Biochem. Biophys. Res. Commun. |
pmid:12437980
|
Sakata R et al. |
Trichostatin A activates the osteopontin gene promoter through AP1 site. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:14985105
|
Steiner E et al. |
SP-transcription factors are involved in basal MVP promoter activity and its stimulation by HDAC inhibitors. |
2004 |
Biochem. Biophys. Res. Commun. |
pmid:15047174
|
Sugita K et al. |
A novel compound, depudecin, induces production of transformation to the flat phenotype of NIH3T3 cells transformed by ras-oncogene. |
1992 |
Biochem. Biophys. Res. Commun. |
pmid:1731795
|
Jang SM et al. |
Transcription factor Sox4 is required for PUMA-mediated apoptosis induced by histone deacetylase inhibitor, TSA. |
2013 |
Biochem. Biophys. Res. Commun. |
pmid:23916609
|
Harada Y et al. |
A hematopoietic-specific transmembrane protein, Art-1, is possibly regulated by AML1. |
2001 |
Biochem. Biophys. Res. Commun. |
pmid:11396961
|
Koyama N et al. |
Differential effects of histone deacetylase inhibitors on interleukin-18 gene expression in myeloid cells. |
2002 |
Biochem. Biophys. Res. Commun. |
pmid:11944905
|
Nadanaka S et al. |
Histone deacetylase-mediated regulation of chondroitin 4-O-sulfotransferase-1 (Chst11) gene expression by Wnt/β-catenin signaling. |
2016 |
Biochem. Biophys. Res. Commun. |
pmid:27751852
|
Park J et al. |
ARD1 binding to RIP1 mediates doxorubicin-induced NF-κB activation. |
2012 |
Biochem. Biophys. Res. Commun. |
pmid:22580278
|
Ghosh AK et al. |
MBP-1 physically associates with histone deacetylase for transcriptional repression. |
1999 |
Biochem. Biophys. Res. Commun. |
pmid:10403782
|
Noh H et al. |
Trichostatin A enhances estrogen receptor-alpha repression in MCF-7 breast cancer cells under hypoxia. |
2016 |
Biochem. Biophys. Res. Commun. |
pmid:26768368
|
Park PH et al. |
Acetylation of histone H3 at lysine 9 by ethanol in rat hepatocytes. |
2003 |
Biochem. Biophys. Res. Commun. |
pmid:12804592
|
Oshima M et al. |
Molecular mechanism of transcriptional repression of AhR repressor involving ANKRA2, HDAC4, and HDAC5. |
2007 |
Biochem. Biophys. Res. Commun. |
pmid:17949687
|
Liu J et al. |
Trichostatin A suppresses lung adenocarcinoma development in Grg1 overexpressing transgenic mice. |
2015 |
Biochem. Biophys. Res. Commun. |
pmid:26086099
|
Lattal KM et al. |
Systemic or intrahippocampal delivery of histone deacetylase inhibitors facilitates fear extinction. |
2007 |
Behav. Neurosci. |
pmid:17907845
|
Miyagawa K et al. |
Possible involvement of histone acetylation in the development of emotional resistance to stress stimuli in mice. |
2012 |
Behav. Brain Res. |
pmid:22963996
|
Moldrich RX et al. |
Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice. |
2013 |
Behav. Brain Res. |
pmid:24103642
|
Knobloch J et al. |
Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease. |
2014 |
Basic Clin. Pharmacol. Toxicol. |
pmid:23981542
|
Li J et al. |
Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells. |
2010 |
Autophagy |
pmid:20543569
|
Liu YL et al. |
Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma. |
2010 |
Autophagy |
pmid:20962572
|
Bao Y et al. |
Identification of trichostatin A as a novel transcriptional up-regulator of scavenger receptor BI both in HepG2 and RAW 264.7 cells. |
2009 |
Atherosclerosis |
pmid:18930459
|
Sanaei M et al. |
Genistein and Trichostatin A Induction of Estrogen Receptor Alpha Gene Expression, Apoptosis and Cell Growth Inhibition in Hepatocellular Carcinoma HepG 2 Cells |
2017 |
Asian Pac. J. Cancer Prev. |
pmid:29286617
|
Shi QQ et al. |
Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling. |
2014 |
Asian Pac. J. Cancer Prev. |
pmid:25292076
|
Zohre S et al. |
Trichostatin A-induced apoptosis is mediated by Kruppel-like factor 4 in ovarian and lung cancer. |
2014 |
Asian Pac. J. Cancer Prev. |
pmid:25169491
|
Yang XL et al. |
Effect of trichostatin A on CNE2 nasopharyngeal carcinoma cells--genome-wide DNA methylation alteration. |
2014 |
Asian Pac. J. Cancer Prev. |
pmid:24969901
|
Cheng DD et al. |
Antitumor activity of histone deacetylase inhibitor trichostatin A in osteosarcoma cells. |
2012 |
Asian Pac. J. Cancer Prev. |
pmid:22799338
|
Zhang QC et al. |
Histone deacetylase inhibitor trichostatin A enhances anti-tumor effects of docetaxel or erlotinib in A549 cell line. |
2012 |
Asian Pac. J. Cancer Prev. |
pmid:22994780
|
Gillespie J et al. |
Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients. |
2012 |
Arthritis Rheum. |
pmid:21952924
|
Farrajota K et al. |
Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism. |
2005 |
Arthritis Rheum. |
pmid:15641079
|
Culley KL et al. |
Class I histone deacetylase inhibition modulates metalloproteinase expression and blocks cytokine-induced cartilage degradation. |
2013 |
Arthritis Rheum. |
pmid:23575963
|
Wang Y et al. |
Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. |
2006 |
Arthritis Rheum. |
pmid:16802366
|
Huber LC et al. |
Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. |
2007 |
Arthritis Rheum. |
pmid:17665426
|
Hemmatazad H et al. |
Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis. |
2009 |
Arthritis Rheum. |
pmid:19404935
|
Cai D et al. |
Histone deacetylase inhibition activates Nrf2 and protects against osteoarthritis. |
2015 |
Arthritis Res. Ther. |
pmid:26408027
|
Misaki K et al. |
Histone deacetylase inhibition alters dendritic cells to assume a tolerogenic phenotype and ameliorates arthritis in SKG mice. |
2011 |
Arthritis Res. Ther. |
pmid:21592365
|
Dje N'Guessan P et al. |
Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells. |
2009 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:19122173
|
Choi JH et al. |
Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice. |
2005 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:16141407
|
Inoue K et al. |
Histone deacetylase inhibitor reduces monocyte adhesion to endothelium through the suppression of vascular cell adhesion molecule-1 expression. |
2006 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:17008592
|
Colussi C et al. |
P300/CBP associated factor regulates nitroglycerin-dependent arterial relaxation by N(ε)-lysine acetylation of contractile proteins. |
2012 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:22859492
|
Nordén R et al. |
Inhibition of protein deacetylation augments herpes simplex virus type 1-activated transcription of host fucosyltransferase genes associated with virus-induced sLex expression. |
2010 |
Arch. Virol. |
pmid:20039087
|
Shinde V et al. |
Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Tox and STOP-Tox tests. |
2017 |
Arch. Toxicol. |
pmid:27188386
|
Pallocca G et al. |
Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. |
2016 |
Arch. Toxicol. |
pmid:26705709
|
Rempel E et al. |
A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. |
2015 |
Arch. Toxicol. |
pmid:26272509
|
Balmer NV et al. |
From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. |
2014 |
Arch. Toxicol. |
pmid:24935251
|
Zapletal O et al. |
Butyrate alters expression of cytochrome P450 1A1 and metabolism of benzo[a]pyrene via its histone deacetylase activity in colon epithelial cell models. |
2017 |
Arch. Toxicol. |
pmid:27830268
|
Cipriano M et al. |
The role of epigenetic modifiers in extended cultures of functional hepatocyte-like cells derived from human neonatal mesenchymal stem cells. |
2017 |
Arch. Toxicol. |
pmid:27909741
|
Lu MC et al. |
Active extracts of wild fruiting bodies of Antrodia camphorata (EEAC) induce leukemia HL 60 cells apoptosis partially through histone hypoacetylation and synergistically promote anticancer effect of trichostatin A. |
2009 |
Arch. Toxicol. |
pmid:18709356
|
Ahn MR et al. |
Trichostatin A, a histone deacetylase inhibitor stimulate CYP3A4 proximal promoter activity in Hepa-I cells. |
2004 |
Arch. Pharm. Res. |
pmid:15180307
|
Han SB and Lee JK |
Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages. |
2009 |
Arch. Pharm. Res. |
pmid:19407980
|
Kim SN et al. |
Regulation of adipocyte differentiation by histone deacetylase inhibitors. |
2009 |
Arch. Pharm. Res. |
pmid:19407971
|
Joung KE et al. |
Antiproliferative effect of trichostatin A and HC-toxin in T47D human breast cancer cells. |
2004 |
Arch. Pharm. Res. |
pmid:15283467
|
Min KN et al. |
Estrogen receptor enhances the antiproliferative effects of trichostatin A and HC-toxin in human breast cancer cells. |
2004 |
Arch. Pharm. Res. |
pmid:15202563
|
Schmidt K et al. |
Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells. |
1999 |
Arch. Pharm. (Weinheim) |
pmid:10575368
|
Cunneen TS et al. |
In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells. |
2009 |
Arch. Ophthalmol. |
pmid:19365017
|
Piotrowska H and Jagodzinski PP |
Glucocorticoid receptor alpha and beta variant expression is associated with ASF/SF2 splicing factor upregulation in HT-29 colon cancer and MCF-7 breast carcinoma cells. |
2009 |
Arch. Med. Res. |
pmid:19427965
|
Hou SY et al. |
Expressions of MAGE-A9 and MAGE-A11 in breast cancer and their expression mechanism. |
2014 |
Arch. Med. Res. |
pmid:24316396
|
Yu L et al. |
Trichostatin A ameliorates myocardial ischemia/reperfusion injury through inhibition of endoplasmic reticulum stress-induced apoptosis. |
2012 |
Arch. Med. Res. |
pmid:22564421
|
Royce SG et al. |
Effects of the histone deacetylase inhibitor, trichostatin A, in a chronic allergic airways disease model in mice. |
2012 |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:22684086
|
Hizume K et al. |
Nano-scale analyses of the chromatin decompaction induced by histone acetylation. |
2010 |
Arch. Histol. Cytol. |
pmid:22572182
|
Zhu K et al. |
Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors. |
2008 |
Arch. Gynecol. Obstet. |
pmid:17680259
|
Diao JS et al. |
Trichostatin A inhibits collagen synthesis and induces apoptosis in keloid fibroblasts. |
2011 |
Arch. Dermatol. Res. |
pmid:21400246
|
Chen T et al. |
Histone acetylation is involved in hsp70 gene transcription regulation in Drosophila melanogaster. |
2002 |
Arch. Biochem. Biophys. |
pmid:12464268
|
Bort R et al. |
Role of hepatocyte nuclear factor 3 gamma in the expression of human CYP2C genes. |
2004 |
Arch. Biochem. Biophys. |
pmid:15130783
|
Adachi T et al. |
Histone deacetylase inhibitors stimulate the susceptibility of A549Â cells to a plasma-activated medium treatment. |
2016 |
Arch. Biochem. Biophys. |
pmid:27470189
|
Katula KS et al. |
Cell cycle specific changes in the human cyclin B1 gene regulatory region as revealed by response to trichostatin A. |
2002 |
Arch. Biochem. Biophys. |
pmid:12054478
|
Garrison PM et al. |
Effects of histone deacetylase inhibitors on the Ah receptor gene promoter. |
2000 |
Arch. Biochem. Biophys. |
pmid:10666294
|
Wood M et al. |
Trichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6. |
2018 |
Arch. Biochem. Biophys. |
pmid:29233643
|
Sichtig N et al. |
Papillomavirus binding factor binds to SAP30 and represses transcription via recruitment of the HDAC1 co-repressor complex. |
2007 |
Arch. Biochem. Biophys. |
pmid:17897615
|
Senawong T et al. |
BCL11A-dependent recruitment of SIRT1 to a promoter template in mammalian cells results in histone deacetylation and transcriptional repression. |
2005 |
Arch. Biochem. Biophys. |
pmid:15639232
|
Chiou SK and Hoa N |
Up-regulation of GADD45alpha expression by NSAIDs leads to apoptotic and necrotic colon cancer cell deaths. |
2009 |
Apoptosis |
pmid:19757064
|
Reddy RM et al. |
Rapid and profound potentiation of Apo2L/TRAIL-mediated cytotoxicity and apoptosis in thoracic cancer cells by the histone deacetylase inhibitor Trichostatin A: the essential role of the mitochondria-mediated caspase activation cascade. |
2007 |
Apoptosis |
pmid:17136498
|
Zhang CZ et al. |
Trichostatin A sensitizes HBx-expressing liver cancer cells to etoposide treatment. |
2011 |
Apoptosis |
pmid:21468663
|
Ninios YP et al. |
Histone H1 subtype preferences of DFF40 and possible nuclear localization of DFF40/45 in normal and trichostatin A-treated NB4 leukemic cells. |
2010 |
Apoptosis |
pmid:19882353
|
Facchetti F et al. |
Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors. |
2004 |
Apoptosis |
pmid:15314285
|
Roh MS et al. |
Mechanism of histone deacetylase inhibitor Trichostatin A induced apoptosis in human osteosarcoma cells. |
2004 |
Apoptosis |
pmid:15314286
|
Luo B et al. |
A possible strategy to produce pigs resistant to porcine reproductive and respiratory syndrome virus. |
2013 |
Antiviral Res. |
pmid:23732571
|
Wilson DW et al. |
Defining the timing of action of antimalarial drugs against Plasmodium falciparum. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23318799
|
Andrews KT et al. |
Potent antimalarial activity of histone deacetylase inhibitor analogues. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18212103
|
Smith WL and Edlind TD |
Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12384361
|
Varma A and Kwon-Chung KJ |
Heteroresistance of Cryptococcus gattii to fluconazole. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20385871
|
Dow GS et al. |
Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18644969
|
Arany I et al. |
Epigenetic modifiers exert renal toxicity through induction of p66shc. |
2011 |
Anticancer Res. |
pmid:21965735
|
Shu ST et al. |
Function and regulatory mechanisms of the candidate tumor suppressor receptor protein tyrosine phosphatase gamma (PTPRG) in breast cancer cells. |
2010 |
Anticancer Res. |
pmid:20651337
|
Höring E et al. |
The histone deacetylase inhibitor trichostatin a promotes apoptosis and antitumor immunity in glioblastoma cells. |
2013 |
Anticancer Res. |
pmid:23564772
|
Dressel U et al. |
Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer. |
2000 Mar-Apr |
Anticancer Res. |
pmid:10810390
|
Kawano T et al. |
Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect. |
2004 Sep-Oct |
Anticancer Res. |
pmid:15517875
|
Noss KR et al. |
Methylation state of the prostate specific membrane antigen (PSMA) CpG island in prostate cancer cell lines. |
2002 May-Jun |
Anticancer Res. |
pmid:12168830
|
Yasuda K et al. |
ERas oncogene expression and epigenetic regulation by histone acetylation in human cancer cells. |
2007 Nov-Dec |
Anticancer Res. |
pmid:18225573
|
Kuwajima A et al. |
The histone deacetylase inhibitor butyrate inhibits melanoma cell invasion of Matrigel. |
2007 Nov-Dec |
Anticancer Res. |
pmid:18225587
|
Jasek E et al. |
Effect of histone deacetylase inhibitors trichostatin A and valproic acid on etoposide-induced apoptosis in leukemia cells. |
2012 |
Anticancer Res. |
pmid:22753739
|
Nadasi E et al. |
Epigenetic modifiers exacerbate oxidative stress in renal proximal tubule cells. |
2009 |
Anticancer Res. |
pmid:19528494
|
Jung AR et al. |
Increased alternative lengthening of telomere phenotypes of telomerase-negative immortal cells upon trichostatin--a treatment. |
2013 |
Anticancer Res. |
pmid:23482750
|
Yap OW et al. |
Epigenetic modifications of the Estrogen receptor beta gene in epithelial ovarian cancer cells. |
2009 |
Anticancer Res. |
pmid:19331143
|
Emionite L et al. |
Histone deacetylase inhibitors enhance retinoid response in human breast cancer cell lines. |
2004 Nov-Dec |
Anticancer Res. |
pmid:15736447
|
Rahim R and Strobl JS |
Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells. |
2009 |
Anticancer Drugs |
pmid:19584707
|
Hong S et al. |
Differential regulation of thrombospondin-1 expression and antiangiogenesis of ECV304 cells by trichostatin A and helixor A. |
2007 |
Anticancer Drugs |
pmid:17704650
|
Monks A et al. |
Gene expression-signature of belinostat in cell lines is specific for histone deacetylase inhibitor treatment, with a corresponding signature in xenografts. |
2009 |
Anticancer Drugs |
pmid:19606018
|
Wittich S et al. |
Effect of inhibitors of histone deacetylase on the induction of cell differentiation in murine and human erythroleukemia cell lines. |
2005 |
Anticancer Drugs |
pmid:15930892
|